Related Experiment Video
Updated: Jul 2, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
Olga Ananieva1, Joanne Darragh, Claus Johansen
1Medical Research Council Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.
Abstract:
The kinases MSK1 and MSK2 are activated 'downstream' of the p38 and Erk1/2 mitogen-activated protein kinases. Here we found that MSK1 and MSK2 were needed to limit the production of proinflammatory cytokines in response to stimulation of primary macrophages with lipopolysaccharide. By inducing transcription of the mitogen-activated protein kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10, MSK1 and MSK2 exerted many negative feedback mechanisms. Deficiency in MSK1 and MSK2 prevented the binding of phosphorylated transcription factors CREB and ATF1 to the promoters of the genes encoding interleukin 10 and DUSP1. Mice doubly deficient in MSK1 and MSK2 were hypersensitive to lipopolysaccharide-induced endotoxic shock and showed prolonged inflammation in a model of toxic contact eczema induced by phorbol 12-myristate 13-acetate. Our results establish MSK1 and MSK2 as key components of negative feedback mechanisms needed to limit Toll-like receptor-driven inflammation.
Insights
Mitogen-activated protein kinase-activated protein kinase 1 (MSK1) and MSK2 limit inflammatory cytokine production. These kinases are crucial for negative feedback in Toll-like receptor-driven inflammation.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Mitogen-activated protein kinases (MAPKs) like p38 and Erk1/2 are key signaling molecules.
- MSK1 and MSK2 are kinases activated downstream of p38 and Erk1/2.
- Toll-like receptor (TLR) signaling initiates inflammatory responses.
Purpose of the Study:
- To investigate the role of MSK1 and MSK2 in regulating inflammatory responses.
- To elucidate the molecular mechanisms by which MSK1 and MSK2 control cytokine production.
- To determine the in vivo significance of MSK1 and MSK2 in inflammatory models.
Main Methods:
- Primary macrophage stimulation with lipopolysaccharide (LPS).
- Analysis of gene transcription, including DUSP1 and IL-10.
- Assessment of transcription factor binding to gene promoters.
- In vivo studies using MSK1 and MSK2 deficient mice in endotoxic shock and contact eczema models.
Main Results:
- MSK1 and MSK2 are essential for limiting pro-inflammatory cytokine production following LPS stimulation.
- MSK1 and MSK2 induce transcription of DUSP1 and IL-10, acting as negative feedback regulators.
- MSK1/MSK2 deficiency impairs CREB and ATF1 binding to IL-10 and DUSP1 gene promoters.
- MSK1/MSK2 deficient mice exhibit heightened sensitivity to LPS-induced endotoxic shock and prolonged inflammation.
Conclusions:
- MSK1 and MSK2 are critical negative feedback components in TLR-driven inflammatory pathways.
- These kinases play a vital role in controlling the magnitude and duration of inflammatory responses.
- Targeting MSK1/MSK2 could offer therapeutic strategies for inflammatory diseases.
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

